Bioresource Technology 2016-01-01

Towards high potential magnetic biocatalysts for on-demand elimination of pharmaceuticals.

Vaidyanathan Vinoth Kumar, Hubert Cabana

Index: Bioresour. Technol. 200 , 81-9, (2015)

Full Text: HTML

Abstract

The present study investigated the applicability of a laccase based bioprocess for the treatment of a mixture containing 13 selected pharmaceuticals. To do so, laccase was immobilized as cross-linked enzyme aggregates (MAC-CLEAs) on amine functionalized magnetic nanoparticles using chitosan/1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride (EDAC) as the cross-linking system. The activity recovery of laccase reached 61.4% under the optimal conditions of MAC-CLEAs formation. The latter exhibited enhanced storage stability over one year at 4°C and showed better temperature resistance compared to its soluble counterpart. The biocatalysts were properly recycled and the catalytic activity recovery was good even after a hundred and fifty batch reactions. Complete removal of pharmaceuticals like acetaminophen, diclofenac, mefenamic acid, atenolol and epoxy carbamazepine and partial removal of fenofibrate, diazepam, trimethoprim, and ketoprofen by laccase was achieved within 12h of incubation, whereas efficient removal of indometacin required the presence of mediator. Copyright © 2015 Elsevier Ltd. All rights reserved.


Related Compounds

  • 1-(3-Dimethylamino...
  • Naproxen
  • 4-Acetamidophenol
  • 3-Aminopropyltriet...
  • Fenofibrate
  • 1-(3-Dimethylamino...
  • Carbamazepine
  • Caffeine
  • ketoprofen
  • Atenolol

Related Articles:

Minimizing the non-specific binding of nanoparticles to the brain enables active targeting of Fn14-positive glioblastoma cells.

2015-02-01

[Biomaterials 42 , 42-51, (2014)]

Altering in vivo macrophage responses with modified polymer properties.

2015-07-01

[Biomaterials 56 , 187-97, (2015)]

Species-dependent binding of new synthesized bicalutamide analogues to albumin by optical biosensor analysis.

2015-01-01

[J. Pharm. Biomed. Anal. 111 , 324-32, (2015)]

Herceptin conjugated PLGA-PHis-PEG pH sensitive nanoparticles for targeted and controlled drug delivery.

2015-06-20

[Int. J. Pharm. 487 , 81-90, (2015)]

Development of poly (I:C) modified doxorubicin loaded magnetic dendrimer nanoparticles for targeted combination therapy.

2014-10-01

[Biomed. Pharmacother. 68(8) , 979-87, (2014)]

More Articles...